跳至主要内容
临床试验/NCT05881070
NCT05881070Unknown不适用

Effectiveness of Mobile-health Self Management on Quality of Life of Patients Undergoing Chemotherapy

Universitas Muhammadiyah Yogyakarta0 个研究点目标入组 50 人开始时间: 2023年6月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
50
主要终点
Patient's Self-efficacy

研究概览

简要总结

The study will design and evaluate the use of mobile-health based self-management on self-efficacy and quality of life of patients undergoing chemotherapy.

详细描述

The study will design and evaluate the use of mobile-health based self-management on self-efficacy and quality of life of patients undergoing chemotherapy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •adult patients diagnosed with cancer
  • •patients who use smart phone

排除标准

  • •patients with cancer with comorbidity

研究组 & 干预措施

Mobile health self-management

Experimental

干预措施: Mobile-health self management (Behavioral)

结局指标

主要结局

Patient's Self-efficacy

时间窗: four weeks

The patients self-efficacy will be measured pre and post intervention. The measurement will use the Self-Efficacy for Managing Chronic Disease Scale. The scale has been widely used in cancer setting. Respondents will rate their confidence to perform six self-management behaviours (1 = 'not at all confident' to 10 = 'totally confident'). A mean score is calculated (range 1 to 10). A high score indicates high self-efficacy.

Patient's Quality of life

时间窗: Four weeks

The patient's quality of life will be assessed before (T0) and after intervention (T1). The measurement will use EORTC. The score will range from 0-100, where higher score reflects a better quality of life.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Erna Rochmawati

Associate Professor

Universitas Muhammadiyah Yogyakarta

相似试验